Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 387 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69,058 | 46,657 |
| Total Cites | 505 | 692 |
| H-index | 12 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 6 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 172 | 209 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 430 | 588 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 412 | 444 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.56 |
| Self-Citation Percentage |
27.02%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 442 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70,650 | 68,677 |
| Total Cites | 470 | 554 |
| H-index | 12 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 185 | 197 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 392 | 466 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 395 | 416 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.33 |
| Self-Citation Percentage |
15.16%
|
|
Muthu, Madaswamy S.
Indian Institute of Technology Banaras Hindu University,
India
2022 Rank: 77,801
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 501 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77,801 | 75,932 |
| Total Cites | 386 | 436 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 166 | 180 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 317 | 358 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 331 | 346 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
11.47%
|
|
Muthu, Madaswamy S.
Indian Institute of Technology Banaras Hindu University,
India
2021 Rank: 92,249
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 626 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,249 | 91,712 |
| Total Cites | 536 | 625 |
| H-index | 13 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 238 | 262 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 439 | 507 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 439 | 462 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.35 |
| Self-Citation Percentage |
14.24%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.